Pemigatinib treatment for
intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid
comprehensive genomic profiling test
Shun Ishido¹*, Nobuharu Tamaki¹*, Kento Inada¹, Jun Itakura¹, Yuka
Takahashi¹, Naoki Uchihara¹, Keito Suzuki¹, Yuki Tanaka¹, Haruka
Miyamoto¹, Michiko Yamada¹, Hiroaki Matsumoto¹, Tsubasa Nobusawa¹,
Taisei Keitoku¹, Kenta Takaura¹, Shohei Tanaka¹, Chiaki Maeyashiki¹,
Yutaka Yasui¹, Kaoru Tsuchiya¹, Hiroyuki Nakanishi¹, Masayuki
Kurosaki¹#, Namiki Izumi¹
*These authors equally contributed to this case report.
#This author (Masayuki Kurosaki) is corresponding
author.
Department of Gastroenterology and Hepatology, Musashino Red Cross
Hospital, Tokyo, Japan
Guarantor of this article: Masayuki Kurosaki